高级搜索
康艾注射液治疗肿瘤的临床应用概况[J]. 肿瘤防治研究, 2014, 41(09): 1045-1048. DOI: 10.3971/j.issn.1000-8578.2014.09.019
引用本文: 康艾注射液治疗肿瘤的临床应用概况[J]. 肿瘤防治研究, 2014, 41(09): 1045-1048. DOI: 10.3971/j.issn.1000-8578.2014.09.019
Review on Clinical Application and Basic Research of Kang'ai Injection on Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(09): 1045-1048. DOI: 10.3971/j.issn.1000-8578.2014.09.019
Citation: Review on Clinical Application and Basic Research of Kang'ai Injection on Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(09): 1045-1048. DOI: 10.3971/j.issn.1000-8578.2014.09.019

康艾注射液治疗肿瘤的临床应用概况

Review on Clinical Application and Basic Research of Kang'ai Injection on Cancer

  • 摘要: 康艾注射液目前为我国常用的抗肿瘤注射液,由人参、黄芪、苦参素组成,主要应用于原发性肝癌、肺癌、直肠癌等恶性肿瘤的治疗,获得了较好疗效。本文就其应用、药效以及安全性等研究作了综述,为安全用药提供依据。

     

    Abstract: Kang'ai Injection is composed of ginseng, astragalus and oxymatrine. It is mainly used in the treatment of cancer, including liver, lung, colorectal cancer, etc. in China and has obtained good curative effect. This review focuses on the application, efficacy and safety to provide evidence for safe medication.

     

/

返回文章
返回